Evidence map›Paper›PMID 26471266›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2015

DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.

Bahman Rostama, Jacqueline E Turner, Guy T Seavey, Christine R Norton, Thomas Gridley, Calvin P H Vary, Lucy Liaw

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Notch Signaling in the Vasculature: Angiogenesis and Angiocrine Functions.Cold Spring Harbor perspectives in medicine · 2023
    Review
  15. Review
  16. Metabolic Reprogramming in Tumor Endothelial Cells.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bahman RostamaFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Jacqueline E TurnerFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Guy T SeaveyFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Christine R NortonFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Thomas GridleyFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Calvin P H VaryFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough.
Lucy LiawFrom the Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough. liawl@mmc.org.
Maine Medical Center · US

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI Dustin Lynn Updike · 2012 to 2026
$60.0M
Progenitor Cell Analysis CoreP30GM106391 · NIGMS · MAINEHEALTH · PI WOJCHOWSKI, DON MICHAEL · 2013 to 2017
$5.7M
Phase III COBRE in Vascular BiologyP30GM103392 · NIGMS · MAINEHEALTH · PI ST. GERMAIN, DONALD L. · 2012 to 2016
$4.7M
Contribution of Notch Signaling to Vascular RemodelingR01HL070865 · NHLBI · MAINE MEDICAL CENTER · PI LIAW, LUCY · 2003 to 2017
$4.6M
Smooth muscle cell integration of differentiation signalsR01HL109652 · NHLBI · MAINEHEALTH · PI LIAW, LUCY · 2012 to 2015
$1.5M
NHLBI NIH HHS 1R01HL109652NHLBI NIH HHS R01 HL070865NHLBI NIH HHS R01HL070865NHLBI NIH HHS R01 HL109652NIGMS NIH HHS 8P30GM103392NIGMS NIH HHS P20 GM103423NIGMS NIH HHS P30 GM103392NIGMS NIH HHS P30 GM106391
6 · The paper itself

Abstract

objectiveBone morphogenetic protein-9 (BMP9)/activin-like kinase-1 and delta-like 4 (DLL4)/Notch promote endothelial quiescence, and we aim to understand mechanistic interactions between the 2 pathways. We identify new targets that contribute to endothelial quiescence and test whether loss of Dll4(+/-) in adult vasculature alters BMP signaling. APPROACH AND

resultsHuman endothelial cells respond synergistically to BMP9 and DLL4 stimulation, showing complete quiescence and induction of HEY1 and HEY2. Canonical BMP9 signaling via activin-like kinase-1-Smad1/5/9 was disrupted by inhibition of Notch signaling, even in the absence of exogenous DLL4. Similarly, DLL4 activity was suppressed when the basal activin-like kinase-1-Smad1/5/9 pathway was inhibited, showing that these pathways are interdependent. BMP9/DLL4 required induction of P27(KIP1) for quiescence, although multiple factors are involved. To understand these mechanisms, we used proteomics data to identify upregulation of thrombospondin-1, which contributes to the quiescence phenotype. To test whether Dll4 regulates BMP/Smad pathways and endothelial cell phenotype in vivo, we characterized the vasculature of Dll4(+/-) mice, analyzing endothelial cells in the lung, heart, and aorta. Together with changes in endothelial structure and vascular morphogenesis, we found that loss of Dll4 was associated with a significant upregulation of pSmad1/5/9 signaling in lung endothelial cells. Because steady-state endothelial cell proliferation rates were not different in the Dll4(+/-) mice, we propose that the upregulation of pSmad1/5/9 signaling compensates to maintain endothelial cell quiescence in these mice.

conclusionsDLL4/Notch and BMP9/activin-like kinase-1 signaling rely on each other's pathways for full activity. This represents an important mechanism of cross talk that enhances endothelial quiescence and sensitively coordinates cellular responsiveness to soluble and cell-tethered ligands.

Indexed as

Cellular SenescenceActivin Receptors, Type IIAdaptor Proteins, Signal TransducingAnimalsAortaBasic Helix-Loop-Helix ProteinsCalcium-Binding ProteinsCell Cycle ProteinsCell ProliferationCells, CulturedCoronary VesselsCyclin-Dependent Kinase Inhibitor p27Endothelial CellsGenotypeGrowth Differentiation Factor 2Growth Differentiation FactorsActivin Receptors, Type IIACVRL1 protein, humanAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix ProteinsCalcium-Binding ProteinsCDKN1B protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27DLL4 protein, humanDLL4 protein, mouseGDF2 protein, humanGrowth Differentiation Factor 2Growth Differentiation FactorsHEY1 protein, humanHEY2 protein, humanIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsNOTCH1 protein, humanReceptor, Notch1Repressor ProteinsSmad Proteins, Receptor-RegulatedThrombospondin 1BMP9cell cycleDLL4endothelial cellNotchquiescence

Identifiers

PMID26471266
PMCPMC4662626
OpenAlexW2178711257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.